Skip to main content

MoneyWorks4Me

Concord Drugs informs about certificate

20 Jan 2024 Evaluate

Concord Drugs has informed that it enclosed Certificate under Regulation 74 (5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended 31.12.2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1886.80
Dr. Reddys Labs. 1386.00
Cipla 1410.00
Lupin 2014.00
Zydus Lifesciences 1205.50
View more..